About
Jeremy Gower is a postdoctoral researcher in the Clinical Malaria Group at QIMR Berghofer. He has extensive expertise in Plasmodium species culturing and multidisciplinary laboratory techniques. With over eight years of experience supporting Phase 1b human volunteer infection studies, he is highly proficient in manufacturing inoculums for induced blood-stage malaria models. His current research, following the completion of his PhD in April 2025, focuses on the biology of zoonotic malaria—particularly Plasmodium knowlesi—utilizing both in vitro and in vivo methods, as well as investigating Plasmodium parasite multispecies growth dynamics.
Research Skills
- Plasmodium cell culture
- Molecular microbiology
- GMP manufacturing including the use of bioreactors
- Manufacture of inoculum for use in the induced blood stage malaria (IBSM) model in healthy human volunteers
- Flow cytometry
- Optical microscopy
- Design and execution of multidisciplinary projects
Professional Associations
Australian Centre of Research Excellence in Malaria Elimination (ACREME) (Fellow)
Australian Society for Parasitology (ASP)(Member)
Funding
QIMR Berghofer Leadership Development Grant “Development of a 12-well plate assay for rapid ex vivo adaptation of Plasmodium knowlesi” – 2025
Publications
Gower JS, Webster R, Westaway JA, Tickner JA, Wang CY, Peters JM, et al. Development of an experimental human blood-stage model for studying Plasmodium knowlesi. medRxiv. 2025:2025.09.07.25334506.
Rebelo M, Pawliw R, Gower J, Webb L, Mitchell H, Pava Z, et al. Parasite viability as a superior measure of antimalarial drug activity in humans. JID. 2021;223(12):2154-63.
Radohery GFR, Walz A, Gumpp C, Cherkaoui-Rbati MH, Gobeau N, Gower J, et al. Parasite viability as a measure of in vivo drug activity in preclinical and early clinical antimalarial drug assessment. AAC. 2022;66(7):e00114-22.